Candel Therapeutics, Inc. (CADL)
6.50
+0.03
(+0.46%)
USD |
NASDAQ |
Dec 12, 10:10
Candel Therapeutics EPS Diluted (Quarterly): -0.2053 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.27M |
| Total Expenses (Quarterly) | 11.27M |
| Enterprise Value | 275.44M |
| Earnings Yield | -8.61% |
| Normalized Earnings Yield | -11.18 |